ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,135, issued on Oct. 27, was assigned to The Regents of the University of California (Oakland, Calif.).
"Programmable epidermal microfluidic valving system for wearable biofluid management and contextual biomarker analysis" was invented by Sam Emaminejad (Los Angeles), Haisong Lin (Los Angeles) and Jiawei Tan (Los Angeles).
According to the abstract* released by the U.S. Patent & Trademark Office: "Active biofluid management may be advantageous to the realization of wearable bioanalytical platforms that can autonomously provide frequent, real-time, and accurate measures of biomarkers in epidermally-retrievable biofluids (e.g., sweat). Accordingly, exemplary implementations include...